Each 0.1 mg of trabectedin chemotherapy administered by injection

This code represents the administration of trabectedin, an antineoplastic agent used in the treatment of certain advanced or metastatic cancers. It is a chemotherapy drug that works by interfering with DNA transcription and repair processes in cancer cells.

This code is used when trabectedin is administered intravenously for the treatment of unresectable or metastatic liposarcoma or leiomyosarcoma, or for patients with advanced ovarian cancer that has recurred after at least two prior platinum-based chemotherapy regimens. Documentation should clearly state the drug name, dosage administered in 0.1 mg increments, and the route of administration.

• Report units based on each 0.1 mg administered; for example, 1.5 mg would be 15 units.
• Ensure the medical record specifies the exact dosage administered to accurately determine the number of units.
• Do not confuse with other antineoplastic agents; verify the specific drug administered is trabectedin.